#AmChamHealthCareCouncil "We could see some clear threads that tied the discussion together. The first is a desire, and determination, to provide better quality care more effectively. The second is a willingness to listen to different perspectives, to learn from them, and to figure a way to align interests and aims. AmCham is now stitching together a summary of the session, including a list of priorities, to share with policymakers in the government and parliament. Our aim is to build working coalitions to address these priorities, and to make Czech health care a competitive advantage for citizens and companies."
How well did Czechia’s health care system survive Covid? What do its leading practitioners and experts think of its current state? What immediate solutions and long term goals would improve their ability to serve citizens? When you ask politicians about health care, you tend to get answers at the two ends of the spectrum. If their party is in power, everything is great. If their party is out of power, everything sucks. The answer, of course, is somewhere in the middle. But where? And what would it take to inch health care closer to perfection? AmCham CZ ‘s Health Care Council, led by Michala Malat of Johnson & Johnson and Vaclav Novotny of Aspironix, recently gathered experts representing a cross-section of the health care market and asked them to answer those questions. As expected, Pavel Hrobon of the Advanced Health Care Institute delivered different advice than David Kolář of AIFP. Miroslav Palat of CzechMed had different immediate priorities than Antonín Hlavinka of Olomouc Hospital, Michal Šnorek of Ceske Budejovice’s hospital,, or Martina Sochmanova of the nursing association. From his vantage point as a doctor, Martin Balik suggested different long term goals than Jitka Vojtova, who assesses health care through insuring patients. And Edita Mullerova sees all of this with the eyes of the patients she represents. Nevertheless, we could see some clear threads that tied the discussion together. The first is a desire, and determination, to provide better quality care more effectively. The second is a willingness to listen to different perspectives, to learn from them, and to figure a way to align interests and aims. AmCham is now stitching together a summary of the session, including a list of priorities, to share with policymakers in the government and parliament. Our aim is to build working coalitions to address these priorities, and to make Czech health care a competitive advantage for citizens and companies. Thanks also to Pavel Sedláček of Pfizer and Karin Bacmanakova of Bristol Myers Squibb for helping us put some order to the discussion, and to Jaroslav Skvrna and Pavel Nevicky of Deloitte for giving a place to meet and a opening framework for the debate. #HealthCare #digitization
